Elefante C, Brancati GE, Torrigiani S, Amadori S, Ricciardulli S, Pistolesi G · Curr Neuropharmacol (2023)
No plain-language summary recorded for this citation — open the paper to read its abstract.
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
32 peer-reviewed studies
What the evidence says
Lithium Orotate doesn't have enough studies with structured effect-size data yet to pool a verdict. Browse the studies below for individual findings.
Most evidence is from high-quality meta-analyses and randomised trials published 1988–2026 with a typical study size of 9 participants.
Based on 32 studies · 2 meta-analyses · 13 RCTs · 221 total participants
Confidence
High confidenceBy outcome
20 studies in the last 5 years · Latest meta-analysis: 2024
Elefante C, Brancati GE, Torrigiani S, Amadori S, Ricciardulli S, Pistolesi G · Curr Neuropharmacol (2023)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Brown EE, Gerretsen P, Pollock B, Graff-Guerrero A · Med Hypotheses (2018)
No plain-language summary recorded for this citation — open the paper to read its abstract.
In plain English: Although it is yet to be determined which is more effective between lithium or lecanemab or donanemab, lithium may be more effective than aducanumab.
Terao I, Kodama W. · Ageing research reviews (2024)
Strawbridge R, Kerr-Gaffney J, Bessa G, Loschi G, Freitas HLO, Pires H · Neurosci Biobehav Rev (2023)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Mauer S, Vergne D, Ghaemi SN · Aust N Z J Psychiatry (2014)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Zusky PM, Biederman J, Rosenbaum JF, Manschreck TC, Gross CC, Weilberg JB · J Clin Psychopharmacol (1988)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Abou-Saleh MT, Coppen A · J Psychiatr Res (1989)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Devanand DP, Crocco E, Forester BP, Husain MM, Lee S, Vahia IV · Am J Geriatr Psychiatry (2022)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Allain P, Le Bouil A, Turcant A, Molinier P, Armand P, Andrianiriana F · Therapie (1994)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Wilson KC, Scott M, Abou-Saleh M, Burns R, Copeland JR · Br J Psychiatry (1995)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Aprahamian I, Santos FS, dos Santos B, Talib L, Diniz BS, Radanovic M · J Clin Psychiatry (2014)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Wilkinson D, Holmes C, Woolford J, Stammers S, North J · Int J Geriatr Psychiatry (2002)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Deliyannides DA, Graff JA, Niño I, Lee S, Husain MM, Forester BP · Int J Geriatr Psychiatry (2023)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Perlis RH, Sachs GS, Lafer B, Otto MW, Faraone SV, Kane JM · Am J Psychiatry (2002)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Gonzalez Arnold J, Salcedo S, Ketter TA, Calabrese JR, Rabideau DJ, Nierenberg AA · J Affect Disord (2015)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Forlenza OV, Coutinho AM, Aprahamian I, Prando S, Mendes LL, Diniz BS · ACS Chem Neurosci (2014)
No plain-language summary recorded for this citation — open the paper to read its abstract.
In plain English: Lithium potentially reduces intracerebral amyloid deposition and tau phosphorylation in AD animal models and may reverse associated cognitive deficits.
Xiao K, Sayed H, Xing J, Zhang XY, Ai J, Kirichek E, Le GH, Wong S, Valentino K, Teopiz KM, Vinberg M, Rosenblat JD, Lo HKY, Zhang MC, McIntyre RS. · Journal of affective disorders (2026)
In plain English: This pilot randomized clinical trial established feasibility, confirmed safety and tolerability, and generated effect size estimates for future trials of low-dose lithium in MCI.
Gildengers AG et al. · JAMA neurology (2026)
In plain English: Future adequately powered RCTs with cognition as a primary endpoint, functional measures, and biomarker outcomes are warranted to clarify lithium's role as a maintenance treatment in psychiatric disorders and its potential neuroprotective effects in neurodegenerative diseases.
Deng R, Shargorodsky A, Teopiz K, Dri CE, Wong S, Le GH, Zheng YJ, McIntyre RS. · CNS spectrums (2026)
In plain English: With a side-effect profile either comparable to, or better than UHR antipsychotic trials, lithium might be explored for further research with UHR young people.
Rice SM, Nelson B, Amminger GP, Francey SM, Phillips LJ, Simmons MB, Ross M, Yuen HP, Yung AR, O'Gorman K, McGorry PD, Wood SJ, Berger GE. · Early intervention in psychiatry (2024)